Zhong Z, Kauffman F C, Thurman R G
Department of Pharmacology, University of North Carolina, Chapel Hill 27599.
Cancer Res. 1991 Sep 1;51(17):4511-5.
Long-chain fatty acids inhibit glucuronidation of benzo(a)pyrene phenols in perfused liver; therefore, this study was designed to investigate interactions of fatty acids with beta-glucuronidase, glucuronosyl transferase, and energy supply. In beta-glucuronidase-deficient C3H/He mice, infusion of oleate (250 microM) increased the release of free benzo(a)pyrene phenols from 14 to 33 nmol/g/h and decreased release of glucuronides into the perfusate from 25 to 17 nmol/g/h. Rates of accumulation of glucuronides in the liver were also diminished from 11 to 4 nmol/g/h after infusion of oleate (250 microM). Fatty acids did not affect the release of benzo(a)pyrene metabolites into bile, and the ratio of free phenol to glucuronide production was increased from 0.57 to 1.30. A similar trend was observed in livers from DBA/2 mice that have beta-glucuronidase. Rates of hydrolysis of benzo(a)pyrene-O-glucuronide were not altered in isolated microsomes by addition of oleoyl coenzyme A (CoA) or octanoyl CoA (10- approximately 100 microM). Thus, we conclude that fatty acids do not alter glucuronidation by acting on beta-glucuronidase. The concentration of cofactors (UDP-glucuronic acid, UDP-glucose, and adenine nucleotides) involved in hepatic conjugation was not altered by infusion of concentrations of oleate (300 microM) that inhibited glucuronidation in perfused livers. When oleate concentrations were increased to 600 microM, UDP-glucuronic acid and UDP-glucose decreased 44 and 49%, respectively, and the ATP:ADP ratio declined concomitantly. Oleoyl CoA inhibited UDP-glucuronosyl transferase noncompetitively (half-maximal inhibition, 10 microM) in microsomes with 3-hydroxy-benzo(a)pyrene or p-nitrophenol as substrate. In contrast, octanoyl CoA was a very poor inhibitor of transferase activity. Inhibition of the transferase by oleoyl CoA was increased markedly by treatment with detergents (Triton X-100), i.e., half-inhibition of glucuronosyl transferase was obtained with about 2 microM oleoyl CoA. Inhibition of UDP-glucuronosyl transferase by oleoyl CoA was also increased in a dose-dependent manner by albumin, possibly due to increasing access of the CoA derivative to the enzyme. Collectively, these data indicate that fatty acids diminish glucuronidation via the formation of acyl CoA compounds that inhibit UDP-glucuronosyl transferase noncompetitively.
长链脂肪酸可抑制灌注肝脏中苯并(a)芘酚的葡萄糖醛酸化;因此,本研究旨在探讨脂肪酸与β-葡萄糖醛酸酶、葡萄糖醛酸基转移酶及能量供应之间的相互作用。在缺乏β-葡萄糖醛酸酶的C3H/He小鼠中,输注油酸盐(250微摩尔)可使游离苯并(a)芘酚的释放量从14纳摩尔/克/小时增至33纳摩尔/克/小时,并使葡萄糖醛酸化物向灌注液中的释放量从25纳摩尔/克/小时降至17纳摩尔/克/小时。输注油酸盐(250微摩尔)后,肝脏中葡萄糖醛酸化物的积累速率也从11纳摩尔/克/小时降至4纳摩尔/克/小时。脂肪酸并不影响苯并(a)芘代谢产物向胆汁中的释放,且游离酚与葡萄糖醛酸化物生成的比例从0.57增至1.30。在具有β-葡萄糖醛酸酶的DBA/2小鼠肝脏中也观察到了类似趋势。添加油酰辅酶A(CoA)或辛酰CoA(10 - 约100微摩尔)后,苯并(a)芘-O-葡萄糖醛酸化物在分离微粒体中的水解速率未发生改变。因此,我们得出结论,脂肪酸并非通过作用于β-葡萄糖醛酸酶来改变葡萄糖醛酸化。参与肝脏结合反应的辅因子(尿苷二磷酸葡萄糖醛酸、尿苷二磷酸葡萄糖和腺嘌呤核苷酸)的浓度,在灌注肝脏中未因输注抑制葡萄糖醛酸化的油酸盐浓度(300微摩尔)而发生改变。当油酸盐浓度增至600微摩尔时,尿苷二磷酸葡萄糖醛酸和尿苷二磷酸葡萄糖分别下降了44%和49%,且ATP:ADP比值随之下降。油酰CoA在以3-羟基苯并(a)芘或对硝基苯酚为底物的微粒体中对尿苷二磷酸葡萄糖醛酸基转移酶具有非竞争性抑制作用(半数最大抑制浓度,10微摩尔)。相比之下,辛酰CoA对转移酶活性的抑制作用非常弱。用去污剂(Triton X-100)处理后,油酰CoA对转移酶的抑制作用显著增强,即约2微摩尔油酰CoA即可使葡萄糖醛酸基转移酶受到半数抑制。白蛋白也以剂量依赖的方式增强了油酰CoA对尿苷二磷酸葡萄糖醛酸基转移酶的抑制作用,这可能是由于CoA衍生物与酶的接触增加所致。总体而言,这些数据表明,脂肪酸通过形成非竞争性抑制尿苷二磷酸葡萄糖醛酸基转移酶的酰基CoA化合物来减少葡萄糖醛酸化。